Table 1. Skin fibroblast information for ASD subjects and controls.
Monogenic ASD |
Sporadic ASD |
Control |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Sex | Age | Ethnicity | Status | Ca2+ signal | ID | Sex | Age | Ethnicity | Status | Ca2+ signal | ID | Sex | Age | Ethnicity | Status | Ca2+ signal |
GM09497 | M | 28 | Caucasian | FXS | 33.4 | AU0001-0201 | M | 29 | Caucasian | Autism | 82.5 | GM00498 | M | 3 | N/A | Healthy | 104.8 |
GM05848 | M | 4 | Caucasian | FXS | 10.8 | AU0027-0201 | F | 24 | Caucasian | Autism | 115.5 | GM01863 | M | 46 | Caucasian | Healthy | 58.5 |
GM05185 | M | 26 | Caucasian | FXS | 11.7 | AU0027-0202 | M | 21 | Caucasian | Autism | 22.9 | GM02185 | M | 36 | Caucasian | Healthy | 107.8 |
GM05131 | M | 3 | Caucasian | FXS | 25.3 | AU0078-0202 | F | 36 | Caucasian | Autism | 96.3 | GM02912 | M | 26 | Caucasian | Healthy | 64.3 |
GM04026 | M | 35 | Caucasian | FXS | 31.4 | AU0120-0202 | M | 15 | Asian | Autism | 24.2 | GM03440 | M | 20 | Causasian | Healthy | 100.0 |
GM04024 | M | 29 | Black | FXS | 113.0 | AU0197-0201 | M | 17 | Hispanic | PDD-NOS | 38.9 | GM04505 | F | 20 | N/A | Healthy | 110.6 |
GM21890 | M | 19 | N/A | PWS | 82.7 | AU0197-0202 | F | 14 | Hispanic | PDD-NOS | 22.6 | GM05659 | M | 1 | Caucasian | Healthy | 40.8 |
GM16548 | F | 5 | Caucasian | RETT | 34.2 | AU0236-0203 | F | 12 | Caucasian | Autism Spectrum | 7.2 | GM07492 | M | 17 | Caucasian | Healthy | 44.7 |
GM07982 | F | 25 | Caucasian | RETT | 75.6 | AU0237-0201 | F | 13 | Caucasian | Autism | 686.6 | GM07753 | M | 17 | N/A | Healthy | 214.6 |
GM06149 | M | 17 | Caucasian | TSC1 | 49.2 | AU0239-0201 | F | 16 | Caucasian | Autism | 21.3 | GM08399 | F | 19 | N/A | Healthy | 62.9 |
GM06148 | M | 43 | Caucasian | TSC1 | 34.3 | AU0239-0203 | F | 6 | Caucasian | Autism Spectrum | 0.5 | GM23973 | M | 19 | Caucasian | Healthy | 42.7 |
GM06121 | M | 22 | Caucasian | TSC2 | 22.8 | AU0243-0201 | M | 2 | Caucasian | Autism | 0.5 | GM23976 | M | 22 | Caucasian | Healthy | 93.0 |
AU0240-0203 | M | 12 | Caucasian | PWS | 2.4 | AU0245-0201 | F | 20 | Caucasian | Autism | 68.4 | ||||||
AU0244-0201 | M | 19 | Caucasian | PWS | 24.8 | AU0245-0202 | F | 18 | Caucasian | Autism Spectrum | 28.0 | ||||||
AU0250-0202 | M | 11 | Caucasian | PWS | 16.4 | AU0249-0202 | F | 10 | Caucasian | Autism | 16.7 | ||||||
AU0251-0202 | M | 8 | Hispanic | Autism | 40.6 | ||||||||||||
AU0251-0203 | M | 5 | Hispanic | Autism | 22.8 | ||||||||||||
AU0252-0201 | M | 4 | Asian | Autism | 20.6 | ||||||||||||
AU0254-0201 | M | 5 | Hispanic | Autism Spectrum | 0.3 | ||||||||||||
AU0254-0202 | F | 3 | Hispanic | Autism | 0.3 | ||||||||||||
AU0256-0201 | M | 5 | Caucasian | Autism | 0.2 | ||||||||||||
AU0256-0202 | M | 3 | Caucasian | Autism | 0.1 | ||||||||||||
AU0257-0202 | M | 3 | Asian | Autism | 1.2 |
Controls are defined as apparently healthy individuals without any known neurodevelopmental disorders (Coriell cell biorepository). Cell lines starting with “GM#” were purchased from the Coriell cell biorepository; cell lines starting with “AU#” were established by UCI CART. The ASD diagnosis was established based on the results of administered appropriate version of ADOS. PDD-NOS = Pervasive Developmental Disorder-Not Otherwise Specified.
Ca2+ signals are presented as percentage of the reference cell line (GM03440).